Skip to main content
. 2011 Sep;13(9):814–822. doi: 10.1111/j.1463-1326.2011.01412.x

Figure 3.

Figure 3

Change in body weight from baseline to week 24 by number and type of OAD at baseline (0/1 or 2; MET only, SU only, or both MET and SU). p Values were calculated from an analysis of variance model with study and baseline OAD use as factors and baseline body weight as a covariate. MET, metformin; OAD, oral antidiabetic drug; SU, sulfonylurea. *Least squares mean.